Skip to content

Comparison Between Intraligamentary Piroxicam and Articaine

Comparative Evaluation of the Efficacy of Intra-ligamentary Injection of 20 Milligram (Mg) Piroxicam Versus 4% Articaine in Management of Endodontic Pain in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03612323
Enrollment
20
Registered
2018-08-02
Start date
2018-11-30
Completion date
2019-08-31
Last updated
2018-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulpitis - Irreversible

Brief summary

Comparing the efficacy of intra-ligamentary Piroxicam and intra-ligamentary Articaine on pain during and after endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.

Detailed description

Owing to the painful nature of endodontic treatment in teeth with symptomatic irreversible pulpitis and difficulty in achieving effective anesthesia particularly in mandibular molars due to various factors such as different bony landmarks, anatomical variations, needle deflection, accessory innervation, so local anesthesia isn't enough in such cases. Piroxicam is a long-acting potent analgesic non selective oxicams derivative, has a half-life of 50 hrs in the plasma.The onset of action of oral Piroxicam is 2-4 hrs, but it is anticipated that injectable piroxicam could produce more rapid onset of action. It could favourably overcome the intense pain up to 48 hrs following the treatment. It is also postulated that the intraligamentary injection enables the application of anti-inflammatory agents in the periapical intraosseous region. Moreover, intra-ligamentary injection of local anesthesia was reported to be an effective and easy way to control severe pain during endodontic treatment mainly in mandibular teeth which are more difficult than maxillary teeth , thus piroxicam may be effective as an adjuvant drug to support the action of local anesthetics.

Interventions

DRUGIntra-ligamentary Piroxicam

Piroxicam is a long-acting potent analgesic non selective oxicams derivative, has a half-life of 50 hrs in the plasma.The onset of action of oral piroxicam is 2-4 hrs, but it is anticipated that injectable piroxicam could produce more rapid onset of action. It could favourably overcome the intense pain up to 48 hrs following the treatment

DRUGIntra-ligamentary Articaine

Articaine is a local anesthetic agent , has been reported to be an effective anesthetic in controlling pain during root canal treatment

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy and medically free patients. * Acute symptomatic irreversible pulpitis of the mandibular first or second molar teeth. * Vital teeth with no history of previous root canal treatment. * Teeth that could be treated endodontically in single visit. * Teeth with normal periodontium, not sensitive to percussion with no periapical radiolucency. * Patients able to understand numerical rating scale and sign the informed consent.

Exclusion criteria

* Known hypersensitivity to piroxicam. * Pregnancy or lactation. * Asthma or allergy to other anti-inflammatory drugs. * History of peptic ulceration. * Teeth associated with swelling or fistulous tract, acute or chronic periapical abscess.

Design outcomes

Primary

MeasureTime frameDescription
Alleviation of post-operative pain severityup to 48 hoursthe patient will be asked to rate the progress of pain on the NRS and inform the investigator with the results,Primary outcome will be collected by the operator through Numerical Rating Scale (NRS) which is an 11-point scale consisting of numbers from 0 through 10; 0 reading represents no pain , 1- 3 readings represent mild pain , 4- 6 readings represent moderate pain , 7- 10 readings represent severe pain No or mild pain will be considered as success while moderate or severe pain will be regarded as failure.

Secondary

MeasureTime frameDescription
Intra-operative pain during access cavity preparation and instrumentation which will be measured ny Numerical Rating Scale (NRS)immediately after injection of the drug up to 2 hours till end of endodontic treatmentthe patient will be asked to rate the progress of pain on the NRS and inform the investigator with the results,secondary outcome will be assessed through Numerical Rating Scale (NRS) which is an 11-point scale consisting of numbers from 0 through 10; 0 reading represents no pain , 1- 3 readings represent mild pain , 4- 6 readings represent moderate pain , 7- 10 readings represent severe pain No or mild pain will be considered as success while moderate or severe pain will be regarded as failure.

Contacts

Primary ContactLobna Elhadad, student
lobna.elhadad@dentistry.cu.edu.eg+201279811117
Backup ContactMarwa Bedeir
M.bedeir81@gmail.com+201006611104

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026